Neurogene’s (NASDAQ:NGNE) Earnings Might Be Weaker Than You Think
Investors appear disappointed with Neurogene Inc.’s (NASDAQ:NGNE) recent earnings, despite the decent statutory profit number. We think that they may be worried about something else, so we did some analysis…